WINDTREE THERAPEUTICS INC /DE/ Operating Expenses
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Operating Expenses of $19.88 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2025-11-19
- WINDTREE THERAPEUTICS INC /DE/ operating expenses for the quarter ending 2025-09-30 was $19.88M, a 319.36% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ operating expenses for the quarter ending 2025-06-30 was $3.98M, a 65.21% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ operating expenses for the quarter ending 2025-03-31 was $4.09M, a 7.15% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ operating expenses for the quarter ending 2024-12-31 was $5.54M, a 11.74% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ operating expenses for fiscal 2024 was $26.14M, a 26.91% increase from fiscal 2023.
- WINDTREE THERAPEUTICS INC /DE/ operating expenses for fiscal 2023 was $20.60M, a 50.17% decline from fiscal 2022.
- WINDTREE THERAPEUTICS INC /DE/ operating expenses for fiscal 2022 was $41.33M, a 46.52% decline from fiscal 2021.
- WINDTREE THERAPEUTICS INC /DE/ operating expenses for fiscal 2021 was $77.28M, a 154.91% increase from fiscal 2020.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2025-09-30 | $19.88M 10-Q · filed 2025-11-19 | $23.87M derived: sum of 2 quarters · filed 2025-11-19 | $27.96M 10-Q · filed 2025-11-19 | $33.50M derived: sum of 4 quarters · filed 2025-11-19 |
| 2025-06-30 | $3.98M 10-Q · filed 2025-08-19 | $8.07M 10-Q · filed 2025-08-19 | $13.62M derived: sum of 3 quarters · filed 2025-08-19 | $18.36M derived: sum of 4 quarters · filed 2025-11-19 |
| 2025-03-31 | $4.09M 10-Q · filed 2025-05-15 | $9.63M derived: sum of 2 quarters · filed 2025-05-15 | $14.37M derived: sum of 3 quarters · filed 2025-11-19 | $25.82M derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-12-31 | $5.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $10.28M derived: sum of 2 quarters · filed 2025-11-19 | $21.73M derived: sum of 3 quarters · filed 2025-11-19 | $26.14M 10-K · filed 2025-04-15 |
| 2024-09-30 | $4.74M 10-Q · filed 2025-11-19 | $16.19M derived: sum of 2 quarters · filed 2025-11-19 | $20.60M 10-Q · filed 2025-11-19 | $25.56M derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-06-30 | $11.45M 10-Q · filed 2025-08-19 | $15.86M 10-Q · filed 2025-08-19 | $20.82M derived: sum of 3 quarters · filed 2025-08-19 | $25.51M derived: sum of 4 quarters · filed 2025-08-19 |
| 2024-03-31 | $4.41M 10-Q · filed 2025-05-15 | $9.36M derived: sum of 2 quarters · filed 2025-05-15 | $14.05M derived: sum of 3 quarters · filed 2025-05-15 | $20.81M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $4.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $9.65M derived: sum of 2 quarters · filed 2025-04-15 | $16.41M derived: sum of 3 quarters · filed 2025-04-15 | $20.60M 10-K · filed 2025-04-15 |
| 2023-09-30 | $4.69M 10-Q · filed 2024-11-26 | $11.45M derived: sum of 2 quarters · filed 2024-11-26 | $15.64M 10-Q · filed 2024-11-26 | $26.45M derived: sum of 4 quarters · filed 2024-11-26 |
| 2023-06-30 | $6.76M 10-Q · filed 2024-08-19 | $10.95M 10-Q · filed 2024-08-19 | $21.76M derived: sum of 3 quarters · filed 2024-08-19 | $26.41M derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | $4.19M 10-Q · filed 2024-05-15 | $15.00M derived: sum of 2 quarters · filed 2024-05-15 | $19.65M derived: sum of 3 quarters · filed 2024-05-15 | $37.19M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $10.81M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $15.46M derived: sum of 2 quarters · filed 2024-04-16 | $33.00M derived: sum of 3 quarters · filed 2024-04-16 | $41.33M 10-K · filed 2024-04-16 |
| 2022-09-30 | $4.65M 10-Q · filed 2023-11-09 | $22.19M derived: sum of 2 quarters · filed 2023-11-09 | $30.52M 10-Q · filed 2023-11-09 | $45.21M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $17.54M 10-Q · filed 2023-08-07 | $25.87M 10-Q · filed 2023-08-07 | $40.56M derived: sum of 3 quarters · filed 2023-08-07 | $48.71M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $8.33M 10-Q · filed 2023-05-15 | $23.02M derived: sum of 2 quarters · filed 2023-05-15 | $31.17M derived: sum of 3 quarters · filed 2023-05-15 | $76.53M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $14.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $22.84M derived: sum of 2 quarters · filed 2023-03-31 | $68.20M derived: sum of 3 quarters · filed 2023-03-31 | $77.28M 10-K · filed 2023-03-31 |
| 2021-09-30 | $8.15M 10-Q · filed 2022-11-14 | $53.51M derived: sum of 2 quarters · filed 2022-11-14 | $62.59M 10-Q · filed 2022-11-14 | $69.55M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $45.36M 10-Q · filed 2022-08-11 | $54.44M 10-Q · filed 2022-08-11 | $61.40M derived: sum of 3 quarters · filed 2022-08-11 | $70.11M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $9.08M 10-Q · filed 2022-05-05 | $16.04M derived: sum of 2 quarters · filed 2022-05-05 | $24.75M derived: sum of 3 quarters · filed 2022-05-05 | $32.69M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $6.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $15.67M derived: sum of 2 quarters · filed 2022-03-31 | $23.61M derived: sum of 3 quarters · filed 2022-03-31 | $30.32M 10-K · filed 2022-03-31 |
| 2020-09-30 | $8.71M 10-Q · filed 2021-11-10 | $16.65M derived: sum of 2 quarters · filed 2021-11-10 | $23.36M 10-Q · filed 2021-11-10 | $27.91M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $7.95M 10-Q · filed 2021-08-05 | $14.65M 10-Q · filed 2021-08-05 | $19.20M derived: sum of 3 quarters · filed 2021-08-05 | $26.39M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $6.70M 10-Q · filed 2021-05-13 | $11.26M derived: sum of 2 quarters · filed 2021-05-13 | $18.44M derived: sum of 3 quarters · filed 2021-05-13 | $25.10M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $4.55M 10-K · filed 2020-04-03 | $11.74M derived: sum of 2 quarters · filed 2020-11-16 | $18.39M derived: sum of 3 quarters · filed 2020-11-16 | $25.09M 10-K · filed 2021-03-29 |
| 2019-09-30 | $7.19M 10-Q · filed 2020-11-16 | $13.84M derived: sum of 2 quarters · filed 2020-11-16 | $20.54M 10-Q · filed 2020-11-16 | $25.69M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $6.65M 10-Q · filed 2020-08-14 | $13.35M 10-Q · filed 2020-08-14 | $18.50M derived: sum of 3 quarters · filed 2020-08-14 | $22.20M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $6.70M 10-Q · filed 2020-05-13 | $11.85M derived: sum of 2 quarters · filed 2020-05-13 | $15.55M derived: sum of 3 quarters · filed 2020-05-13 | $19.64M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $5.16M 10-K · filed 2020-04-03 | $8.85M derived: sum of 2 quarters · filed 2020-04-03 | $12.94M derived: sum of 3 quarters · filed 2020-04-03 | $17.98M 10-K · filed 2020-04-03 |
| 2018-09-30 | $3.70M 10-K · filed 2020-04-03 | $7.78M derived: sum of 2 quarters · filed 2020-04-03 | $12.83M 10-Q · filed 2019-11-14 | $16.43M derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-06-30 | $4.09M 10-K · filed 2020-04-03 | $9.13M 10-Q · filed 2019-08-14 | $12.73M derived: sum of 3 quarters · filed 2020-04-03 | $17.54M derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-03-31 | $5.04M 10-K · filed 2020-04-03 | $8.64M derived: sum of 2 quarters · filed 2020-04-03 | $13.46M derived: sum of 3 quarters · filed 2020-04-03 | $20.74M derived: sum of 4 quarters · filed 2020-04-03 |
| 2017-12-31 | $3.60M 10-K/A · filed 2019-04-23 | $8.41M derived: sum of 2 quarters · filed 2019-04-23 | $15.70M derived: sum of 3 quarters · filed 2019-04-23 | $24.03M 10-K/A · filed 2019-04-23 |
| 2017-09-30 | $4.81M 10-K/A · filed 2019-04-23 | $12.10M derived: sum of 2 quarters · filed 2019-04-23 | $20.43M 10-Q · filed 2018-11-14 | $27.70M derived: sum of 4 quarters · filed 2019-04-23 |
| 2017-06-30 | $7.29M 10-K/A · filed 2019-04-23 | $15.62M 10-Q · filed 2018-08-14 | $22.89M derived: sum of 3 quarters · filed 2019-04-23 | $31.58M derived: sum of 4 quarters · filed 2019-04-23 |
| 2017-03-31 | $8.34M 10-K/A · filed 2019-04-23 | $15.60M derived: sum of 2 quarters · filed 2019-04-23 | $24.30M derived: sum of 3 quarters · filed 2019-04-23 | $34.40M derived: sum of 4 quarters · filed 2019-04-23 |
| 2016-12-31 | $7.27M 10-K · filed 2018-04-17 | $15.96M derived: sum of 2 quarters · filed 2018-04-17 | $26.06M derived: sum of 3 quarters · filed 2018-04-17 | $40.08M 10-K · filed 2018-04-17 |
| 2016-09-30 | $8.69M 10-K · filed 2018-04-17 | $18.79M derived: sum of 2 quarters · filed 2018-04-17 | $32.81M 10-Q · filed 2017-11-14 | $43.25M derived: sum of 4 quarters · filed 2018-04-17 |
| 2016-06-30 | $10.10M 10-K · filed 2018-04-17 | $24.12M 10-Q · filed 2017-08-21 | $34.55M derived: sum of 3 quarters · filed 2018-04-17 | $43.06M derived: sum of 4 quarters · filed 2018-04-17 |
| 2016-03-31 | $14.02M 10-K · filed 2018-04-17 | $24.45M derived: sum of 2 quarters · filed 2018-04-17 | $32.96M derived: sum of 3 quarters · filed 2018-04-17 | $43.47M derived: sum of 4 quarters · filed 2018-04-17 |
| 2015-12-31 | $10.44M 10-K · filed 2017-03-31 | $18.95M derived: sum of 2 quarters · filed 2017-03-31 | $29.46M derived: sum of 3 quarters · filed 2017-03-31 | $40.82M 10-K · filed 2017-03-31 |
| 2015-09-30 | $8.51M 10-K · filed 2017-03-31 | $19.02M derived: sum of 2 quarters · filed 2017-03-31 | $30.39M 10-Q · filed 2016-11-14 | $42.80M derived: sum of 4 quarters · filed 2017-03-31 |
| 2015-06-30 | $10.51M 10-K · filed 2017-03-31 | $21.88M 10-Q · filed 2016-08-10 | $34.29M derived: sum of 3 quarters · filed 2017-03-31 | $45.14M derived: sum of 4 quarters · filed 2017-03-31 |
| 2015-03-31 | $11.36M 10-K · filed 2017-03-31 | $23.77M derived: sum of 2 quarters · filed 2017-03-31 | $34.63M derived: sum of 3 quarters · filed 2017-03-31 | $46.66M derived: sum of 4 quarters · filed 2017-03-31 |
| 2014-12-31 | $12.41M 10-K · filed 2016-03-29 | $23.26M derived: sum of 2 quarters · filed 2016-03-29 | $35.30M derived: sum of 3 quarters · filed 2016-03-29 | $46.09M 10-K · filed 2016-03-29 |
| 2014-09-30 | $10.85M 10-K · filed 2016-03-29 | $22.89M derived: sum of 2 quarters · filed 2016-03-29 | $33.68M 10-Q · filed 2015-11-05 | $44.02M derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-06-30 | $12.04M 10-K · filed 2016-03-29 | $22.83M 10-Q · filed 2015-08-10 | $33.17M derived: sum of 3 quarters · filed 2016-03-29 | $44.04M derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-03-31 | $10.79M 10-K · filed 2016-03-29 | $21.13M derived: sum of 2 quarters · filed 2016-03-29 | $32.01M derived: sum of 3 quarters · filed 2016-03-29 | $43.00M derived: sum of 4 quarters · filed 2016-03-29 |
| 2013-12-31 | $10.34M 10-K · filed 2015-03-16 | $21.21M derived: sum of 2 quarters · filed 2015-03-16 | $32.20M derived: sum of 3 quarters · filed 2015-03-16 | $44.90M 10-K · filed 2015-03-16 |
| 2013-09-30 | $10.87M 10-K · filed 2015-03-16 | $21.86M derived: sum of 2 quarters · filed 2015-03-16 | $34.56M 10-Q · filed 2014-11-07 | $47.18M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | $10.99M 10-K · filed 2015-03-16 | $23.68M 10-Q · filed 2014-08-07 | $36.30M derived: sum of 3 quarters · filed 2015-03-16 | $46.30M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | $12.69M 10-K · filed 2015-03-16 | $25.31M derived: sum of 2 quarters · filed 2015-03-16 | $35.31M derived: sum of 3 quarters · filed 2015-03-16 | $44.13M derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | $12.62M 10-K · filed 2014-03-17 | $22.62M derived: sum of 2 quarters · filed 2014-03-17 | $31.43M derived: sum of 3 quarters · filed 2014-03-17 | $38.01M 10-K · filed 2015-03-16 |
| 2012-09-30 | $10.00M 10-K · filed 2014-03-17 | $18.81M derived: sum of 2 quarters · filed 2014-03-17 | $25.39M 10-Q · filed 2013-11-12 | $31.30M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | $8.82M 10-K · filed 2014-03-17 | $15.40M 10-Q · filed 2013-08-08 | $21.30M derived: sum of 3 quarters · filed 2014-03-17 | $27.47M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $6.58M 10-K · filed 2014-03-17 | $12.48M derived: sum of 2 quarters · filed 2014-03-17 | $18.65M derived: sum of 3 quarters · filed 2014-03-17 | $25.23M derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | $5.90M 10-K · filed 2013-03-15 | $12.07M derived: sum of 2 quarters · filed 2013-03-15 | $18.65M derived: sum of 3 quarters · filed 2013-03-15 | $25.09M 10-K · filed 2014-03-17 |
| 2011-09-30 | $6.17M 10-K · filed 2013-03-15 | $12.75M derived: sum of 2 quarters · filed 2013-03-15 | $19.19M 10-Q · filed 2012-11-14 | $25.22M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | $6.58M 10-K · filed 2013-03-15 | $13.02M 10-Q · filed 2012-08-14 | $19.05M derived: sum of 3 quarters · filed 2013-03-15 | $25.26M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | $6.44M 10-K · filed 2013-03-15 | $12.47M derived: sum of 2 quarters · filed 2013-03-15 | $18.68M derived: sum of 3 quarters · filed 2013-03-15 | $24.90M derived: sum of 4 quarters · filed 2013-03-15 |
| 2010-12-31 | $6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $12.23M derived: sum of 2 quarters · filed 2013-03-15 | $18.46M derived: sum of 3 quarters · filed 2013-03-15 | $25.53M 10-K · filed 2013-03-15 |
| 2010-09-30 | $6.20M 10-Q · filed 2011-11-14 | $12.43M derived: sum of 2 quarters · filed 2011-11-14 | $19.50M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $6.23M 10-Q · filed 2011-08-15 | $13.29M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |